Summit Partners Public Asset Management »

Oruka Therapeutics shares owned by Summit Partners Public Asset Management

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by Summit Partners Public Asset Management from 13F filings

Historical chart of Summit Partners Public Asset Management investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Summit Partners Public Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Summit Partners Public Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $63M 658k 95.17

More positions owned by Summit Partners Public Asset Management

Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Sandisk Corp (SNDK)
Tower Semiconductor Shs New (TSEM)
Digitalocean Hldgs (DOCN)
Guardant Health (GH)
Hut 8 Corp (HUT)
MKS Instruments (MKSI)
Nebius Group Shs Class A (NBIS)
Solaris Energy Infras Com Cl A (SEI)
Snowflake Com Shs (SNOW)
NVIDIA Corporation (NVDA)
Datadog Cl A Com (DDOG)
Natera (NTRA)
Onto Innovation (ONTO)
Silicon Motion Technology Sponsored Adr (SIMO)

View all positions for Summit Partners Public Asset Management

Top funds holding Oruka Therapeutics

FMR
BlackRock
VR Adviser
Fairmount Funds Management
Rtw Investments
Vanguard Capital Management
Paradigm Biocapital Advisors
Deep Track Capital
Bellevue Group
Franklin Resources
State Street Corporation
Remedium Capital Partners
RA Capital Management
Viking Global Investors
Geode Capital Management

View all funds holding Oruka Therapeutics